|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-1-15
|
|
pubmed:abstractText |
This study was designed to evaluate a combined modality treatment for malignant gliomas using radiation therapy with a radiosensitizer and an adjuvant chemotherapy regimen designed to modify resistance to BNCU.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
pubmed-author:ChandlerK LKL,
pubmed-author:ChangS MSM,
pubmed-author:DavisR LRL,
pubmed-author:GutinP HPH,
pubmed-author:KrouwerH GHG,
pubmed-author:LambornKK,
pubmed-author:LarsonD ADA,
pubmed-author:LevinV AVA,
pubmed-author:MackE EEE,
pubmed-author:MalekEE,
pubmed-author:McDermottM WMW,
pubmed-author:PhillipsT LTL,
pubmed-author:PradosM DMD,
pubmed-author:RabbittJ EJE,
pubmed-author:SneedP KPK,
pubmed-author:WardW JWJ,
pubmed-author:WarnickR ERE,
pubmed-author:WilsonC BCB
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
57-63
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9422558-Adolescent,
pubmed-meshheading:9422558-Adult,
pubmed-meshheading:9422558-Aged,
pubmed-meshheading:9422558-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9422558-Brain Neoplasms,
pubmed-meshheading:9422558-Carmustine,
pubmed-meshheading:9422558-Combined Modality Therapy,
pubmed-meshheading:9422558-Disease Progression,
pubmed-meshheading:9422558-Female,
pubmed-meshheading:9422558-Glioblastoma,
pubmed-meshheading:9422558-Glioma,
pubmed-meshheading:9422558-Humans,
pubmed-meshheading:9422558-Hydroxyurea,
pubmed-meshheading:9422558-Male,
pubmed-meshheading:9422558-Middle Aged,
pubmed-meshheading:9422558-Proportional Hazards Models,
pubmed-meshheading:9422558-Prospective Studies,
pubmed-meshheading:9422558-Radiotherapy Dosage,
pubmed-meshheading:9422558-Survival Analysis,
pubmed-meshheading:9422558-Thioguanine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
|
|
pubmed:affiliation |
Department of Neurosurgery, University of California San Francisco, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
